S
Serina Therapeutics, Inc. (SER)
ASE – Real Time Price. Currency in USD
1.81
-0.01 (-0.55%)
At close: Jun 26, 2026, 4:00 PM EDT
1.73
-0.08 (-4.42%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
1.81
-0.01 (-0.55%)
At close: Jun 26, 2026, 4:00 PM EDT
1.73
-0.08 (-4.42%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $24.5M significantly exceed its total debt $3.2M, ensuring strong financial flexibility
Total current assets $26.5M exceed Total current liabilities $6.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-33.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.18 | 6.05 | 10 | |
| Quick ratio | 4.18 | 5.63 | 10 | |
| Debt to Equity | 0.18 | 0.30 | 9.0 | |
| Debt to Assets | 0.12 | 1.04 | 8.0 | |
| Interest coverage | -33.23 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 3M | 56K | 130K | 130K |
| Gross Profit | -145K | 3M | -138K | 45K | 50K |
| Operating Income | -7M | -3M | -17M | -24M | -24M |
| Net Income | -10M | 5M | -11M | -19M | -21M |
| EBITDA | -7M | -3M | -17M | -24M | -24M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | 30.3 | 5.5 |
| Next quarter | N/A | -2.22 | 1.0 |
| Current year | -100 | 3.66 | 2.5 |
| Next year | N/A | 31.52 | 5.5 |
| Weighted average score | 3.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -106.76 | -87.09 | 23.87 | 5.5 |
| Y/Y | 999 | -43.31 | -18.36 | -6.26 | 3.3 |
| 3y average | 344.31 | -77.73 | N/A | -143.64 | 3.3 |
| 5y average | 181.4 | -46.72 | N/A | -81.35 | 3.3 |
| Weighted average score | 3.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |